Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-08-30

Clinical Trial Update: A Study in Asthmatic Children (6 to <12 Yrs) Comparing Single Doses of Formoterol and Foradil® Evaluating Efficacy [Phase 2]

View source ↗

Summary

Phase 2 study in asthmatic children (6 to <12 years) comparing single doses of Formoterol and Foradil to evaluate efficacy; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Foradil (formoterol)
  • Formoterol (formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Asthma | Phase 2 | Status: COMPLETED | Results posted: 2013-08-30